![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NEUROPHARMACOLOGY
-1 Receptor Gene and Protein Expression in Brain Regions Involved in Addiction and Reward
College of Pharmacy (Y.L., G.-D.C., R.R.M.) and Department of Surgery (M.R.L., D.J.B.), University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma; Veteran's Affairs Medical Center, Oklahoma City, Oklahoma (M.R.L., D.J.B.); and University of Mississippi, University, Mississippi (R.R.M.)
Receptors have recently been implicated in the actions of cocaine, and antagonists of these receptors prevent many acute and subchronic cocaine effects. A previous study revealed that the immediate early gene fra-2 is up-regulated after cocaine administration, and this effect is prevented by the
-1 receptor antagonist BD1063 [1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine]. In the present study, the effects of cocaine and BD1063 on the expression of six fos and jun genes were evaluated in mouse brains using cDNA microarrays. Several of these genes were altered by cocaine, but only the alteration in fra-2 was prevented by BD1063. The time courses of fra-2 and
-1 receptor gene and protein expression in different brain regions were also determined. Cocaine up-regulated fra-2, which was followed by a later up-regulation of
-1 receptors. The cocaine-induced up-regulation of fra-2 and
-1 receptor genes and proteins were detected in whole brain, striatum, and cortex, but not in cerebellum. All of these cocaine-induced effects were prevented by BD1063. The interaction between cocaine, fra-2, and
-1 receptors involves brain regions that are established components of the neural circuit for reward, suggesting that they may contribute to the enduring changes that underlie the cellular basis of drug abuse.
Address correspondence to: Dr. Rae R. Matsumoto, University of Mississippi, Department of Pharmacology, 303 Faser Hall, University, MS 38677. E-mail: rmatsumo{at}olemiss.edu
This article has been cited by other articles:
![]() |
Y. Liu and R. R. Matsumoto Alterations in Fos-Related Antigen 2 and {sigma}1 Receptor Gene and Protein Expression Are Associated with the Development of Cocaine-Induced Behavioral Sensitization: Time Course and Regional Distribution Studies J. Pharmacol. Exp. Ther., October 1, 2008; 327(1): 187 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cormaci, T. Mori, T. Hayashi, and T.-P. Su Protein Kinase A Activation Down-Regulates, Whereas Extracellular Signal-Regulated Kinase Activation Up-Regulates {sigma}-1 Receptors in B-104 Cells: Implication for Neuroplasticity J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 202 - 210. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Fumagalli, F. Bedogni, A. Frasca, L. Di Pasquale, G. Racagni, and M. A. Riva Corticostriatal Up-Regulation of Activity-Regulated Cytoskeletal-Associated Protein Expression after Repeated Exposure to Cocaine Mol. Pharmacol., November 1, 2006; 70(5): 1726 - 1734. [Abstract] [Full Text] [PDF] |
||||